• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

60至90日龄患细支气管炎婴儿的隐匿性严重细菌感染:一项系统评价

Occult serious bacterial infection in infants younger than 60 to 90 days with bronchiolitis: a systematic review.

作者信息

Ralston Shawn, Hill Vanessa, Waters Ami

机构信息

University of Texas Health Science Center San Antonio, 7703 Floyd Curl Drive, San Antonio, TX 78229, USA.

出版信息

Arch Pediatr Adolesc Med. 2011 Oct;165(10):951-6. doi: 10.1001/archpediatrics.2011.155.

DOI:10.1001/archpediatrics.2011.155
PMID:21969396
Abstract

OBJECTIVE

To summarize the risk of occult serious bacterial infection in the youngest febrile infants presenting with either clinical bronchiolitis or respiratory syncytial virus infection.

DATA SOURCES

We performed a systematic search of the Medline database for studies reporting rates of serious bacterial infection in infants younger than 90 days with clinical bronchiolitis and/or respiratory syncytial virus infection.

STUDY SELECTION

Studies reporting on cultures performed at the time of presentation to care and providing a denominator, ie, total number of each type of culture obtained, were analyzed.

MAIN EXPOSURE

Admission for bronchiolitis.

MAIN OUTCOME MEASURES

Age-specific rates of urinary tract infection, bacteremia, and meningitis were extracted.

RESULTS

The weighted rate of urinary tract infections in the youngest infants in the 11 studies analyzed was 3.3% (95% confidence interval, 1.9%-5.7%). No case of bacteremia was reported in 8 of 11 studies. No case of meningitis was reported in any of the studies. Summary statistics for meningitis and bacteremia are not provided because of an excess of zero events in these samples.

CONCLUSIONS

A screening approach to culturing for serious bacterial infections in febrile infants presenting with bronchiolitis or respiratory syncytial virus infection is very low yield. The rate of urine cultures positive for bacteria remains significant, though asymptomatic bacteriuria may confound these results.

摘要

目的

总结患有临床毛细支气管炎或呼吸道合胞病毒感染的最小龄发热婴儿发生隐匿性严重细菌感染的风险。

数据来源

我们对Medline数据库进行了系统检索,以查找报告90日龄以下患有临床毛细支气管炎和/或呼吸道合胞病毒感染的婴儿严重细菌感染发生率的研究。

研究选择

分析报告就诊时进行的培养并提供分母(即每种培养类型获得的总数)的研究。

主要暴露因素

毛细支气管炎入院。

主要结局指标

提取特定年龄的尿路感染、菌血症和脑膜炎发生率。

结果

在分析的11项研究中,最小龄婴儿尿路感染的加权发生率为3.3%(95%置信区间,1.9%-5.7%)。11项研究中的8项未报告菌血症病例。所有研究均未报告脑膜炎病例。由于这些样本中零事件过多,未提供脑膜炎和菌血症的汇总统计数据。

结论

对患有毛细支气管炎或呼吸道合胞病毒感染的发热婴儿进行严重细菌感染培养的筛查方法阳性率很低。尿培养细菌阳性率仍然较高,尽管无症状菌尿可能会混淆这些结果。

相似文献

1
Occult serious bacterial infection in infants younger than 60 to 90 days with bronchiolitis: a systematic review.60至90日龄患细支气管炎婴儿的隐匿性严重细菌感染:一项系统评价
Arch Pediatr Adolesc Med. 2011 Oct;165(10):951-6. doi: 10.1001/archpediatrics.2011.155.
2
Glucocorticoids for acute viral bronchiolitis in infants and young children.糖皮质激素用于婴幼儿急性病毒性细支气管炎
Cochrane Database Syst Rev. 2004(3):CD004878. doi: 10.1002/14651858.CD004878.
3
WITHDRAWN: Glucocorticoids for acute viral bronchiolitis in infants and young children.撤回:糖皮质激素用于婴幼儿急性病毒性细支气管炎。
Cochrane Database Syst Rev. 2008 Jan 23(1):CD004878. doi: 10.1002/14651858.CD004878.pub2.
4
Palivizumab for immunoprophylaxis of respiratory syncytial virus (RSV) bronchiolitis in high-risk infants and young children: a systematic review and additional economic modelling of subgroup analyses.帕利珠单抗预防高危婴儿和幼儿呼吸道合胞病毒(RSV)毛细支气管炎的免疫预防作用:亚组分析的系统评价和额外的经济建模。
Health Technol Assess. 2011 Jan;15(5):iii-iv, 1-124. doi: 10.3310/hta15050.
5
Immunoglobulin treatment for hospitalised infants and young children with respiratory syncytial virus infection.免疫球蛋白治疗住院婴儿和幼儿呼吸道合胞病毒感染。
Cochrane Database Syst Rev. 2023 Oct 23;10(10):CD009417. doi: 10.1002/14651858.CD009417.pub3.
6
Heliox for croup in children.氦氧混合气治疗儿童喉炎。
Cochrane Database Syst Rev. 2021 Aug 16;8(8):CD006822. doi: 10.1002/14651858.CD006822.pub6.
7
Topical antimicrobial agents for treating foot ulcers in people with diabetes.用于治疗糖尿病患者足部溃疡的局部抗菌剂。
Cochrane Database Syst Rev. 2017 Jun 14;6(6):CD011038. doi: 10.1002/14651858.CD011038.pub2.
8
Different corticosteroids and regimens for accelerating fetal lung maturation for babies at risk of preterm birth.不同的皮质类固醇药物和方案用于加速有早产风险的婴儿的胎儿肺成熟。
Cochrane Database Syst Rev. 2022 Aug 9;8(8):CD006764. doi: 10.1002/14651858.CD006764.pub4.
9
Antenatal corticosteroids prior to planned caesarean at term for improving neonatal outcomes.择期剖宫产术前应用产前皮质激素以改善新生儿结局。
Cochrane Database Syst Rev. 2021 Dec 22;12(12):CD006614. doi: 10.1002/14651858.CD006614.pub4.
10
Drugs for preventing postoperative nausea and vomiting in adults after general anaesthesia: a network meta-analysis.成人全身麻醉后预防术后恶心呕吐的药物:网状Meta分析
Cochrane Database Syst Rev. 2020 Oct 19;10(10):CD012859. doi: 10.1002/14651858.CD012859.pub2.

引用本文的文献

1
Serious bacterial infections in infants younger than 90 days of age with acute bronchiolitis.90日龄以下患有急性细支气管炎的婴儿的严重细菌感染。
Eur J Pediatr. 2025 Jul 22;184(8):494. doi: 10.1007/s00431-025-06340-0.
2
Assessing the Risk of Urinary Tract Infection and Invasive Bacterial Infection in Febrile Infants Aged 7-90 Days With COVID-19.评估7至90日龄感染新型冠状病毒肺炎的发热婴儿发生尿路感染和侵袭性细菌感染的风险
Cureus. 2025 Apr 16;17(4):e82405. doi: 10.7759/cureus.82405. eCollection 2025 Apr.
3
Performance of AAP CPG for Ineligible Well-Appearing Febrile Infants Aged 8-60 Days.
不适合 AAP CPG 的表现 8-60 天外观良好发热婴儿。
Hosp Pediatr. 2024 Dec 1;14(12):e509-e512. doi: 10.1542/hpeds.2023-007458.
4
Occult Serious Bacterial Infections in Neonates and Infants Up to Three Months of Age with Bronchiolitis: Are Invasive Cultures Required?年龄达三个月的毛细支气管炎新生儿及婴儿的隐匿性严重细菌感染:是否需要进行侵入性培养?
Antibiotics (Basel). 2024 Jul 26;13(8):702. doi: 10.3390/antibiotics13080702.
5
A quality improvement approach to improving care of febrile infants.一种改善发热婴儿护理的质量改进方法。
Paediatr Child Health. 2023 Nov 20;29(3):135-143. doi: 10.1093/pch/pxad070. eCollection 2024 Jun.
6
Conundrums in the Management of Febrile Infants under Three Months of Age and Future Research.三个月以下发热婴儿的管理难题与未来研究
Antibiotics (Basel). 2024 Jan 16;13(1):88. doi: 10.3390/antibiotics13010088.
7
Seasonal Prevalence of Respiratory Pathogens Among Children in the United Arab Emirates: A Multicenter Cross-Sectional Study in the Pre-COVID-19 Era.阿拉伯联合酋长国儿童呼吸道病原体的季节性流行情况:COVID-19大流行前时代的一项多中心横断面研究
Cureus. 2023 Sep 14;15(9):e45204. doi: 10.7759/cureus.45204. eCollection 2023 Sep.
8
CA FIRST (California Febrile Infant Risk Stratification Tool) Algorithm Development in a Learning Health System.CA FIRST(加利福尼亚发热婴儿风险分层工具)在学习型健康系统中的算法开发。
Perm J. 2023 Sep 15;27(3):92-98. doi: 10.7812/TPP/23.030. Epub 2023 Aug 10.
9
Does prophylactic antibiotics post pediatric pyeloplasty reduce the incidence of febrile UTIs?预防性抗生素在小儿肾盂成形术后是否能降低发热性尿路感染的发生率?
BMC Urol. 2023 Aug 8;23(1):133. doi: 10.1186/s12894-023-01301-x.
10
The prevalence of serious bacterial infections in infants 90 days and younger with viral respiratory tract infections.90 天及以下月龄婴儿病毒呼吸道感染的严重细菌性感染发生率。
Saudi Med J. 2022 Sep;43(9):1007-1012. doi: 10.15537/smj.2022.43.9.20220400.